Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A2 | P19784 | 2/20 | 0.35 |
| ▸ | CSNK2B | P67870 | 2/20 | 0.35 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.35 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | SLC14A1 | Q13336 | 1/20 | 0.34 |
| ▸ | PLK1 | P53350 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29991602 | 0.87 | POLB (0.42) | CSNK2A2CSNK2BCSNK2A1NOTUMALDH1A1 | |
| SCHEMBL31045214 | 0.84 | KDM4E (0.38) | CSNK2A2CSNK2BCSNK2A1ALDH1A1SMN1; SMN2 | |
| SCHEMBL163783 | 0.82 | MAPT (0.40) | CSNK2A2CSNK2BCSNK2A1NOTUMALDH1A1 | |
| SCHEMBL167507 | 0.79 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2KDM4EHTTKMT2A | |
| SCHEMBL5432011 | 0.77 | MAPT (0.37) | CSNK2A2CSNK2BCSNK2A1ALDH1A1SMN1; SMN2 | |
| SCHEMBL1969445 | 0.77 | KDM4E (0.36) | CSNK2A2CSNK2BCSNK2A1NOTUMALDH1A1 | |
| SCHEMBL26038536 | 0.75 | HTR2C (0.43) | ALDH1A1SMN1; SMN2MAPK1KDM4EHTT | |
| SCHEMBL7100819 | 0.73 | CSNK2A2 (0.46) | CSNK2A2CSNK2BCSNK2A1NOTUMALDH1A1 | |
| SCHEMBL29991488 | 0.72 | KDM4E (0.34) | ALDH1A1KDM4EMAPT | |
| SCHEMBL8334672 | 0.72 | RARA (0.41) | ALDH1A1SMN1; SMN2KDM4EHPGDHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240279236-A1 | COMPOUNDS AND METHODS OF TREATING TUBERCULOSIS | FIMBRION THERAPEUTICS, INC. (US) | 2024-08-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240279236-A1 | COMPOUNDS AND METHODS OF TREATING TUBERCULOSIS | G6PD, SDHA, NQO1 | CSNK2A2 2712/4885CSNK2B 2783/4885CSNK2A1 2965/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.